2seventy bio Inc.

NASDAQ: TSVT · Real-Time Price · USD
5.00
0.00 (0.00%)
At close: May 12, 2025, 3:59 PM

2seventy bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-57.25M -217.57M -254.15M -292.21M
Depreciation & Amortization
7.1M 10.29M 11.53M 16.35M
Stock-Based Compensation
12.15M 32.16M 41.04M 54.63M
Other Working Capital
7.4M 3.03M -36.2M 13.34M
Other Non-Cash Items
-50M 5.66M 317K 869K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3M 2.6M -35.87M 13.33M
Operating Cash Flow
-85M -166.86M -237.13M -207.03M
Capital Expenditures
-707K -13.87M -22.84M -19.57M
Cash Acquisitions
n/a n/a -34.54M n/a
Purchase of Investments
-127.47M -246.74M -145.91M n/a
Sales Maturities Of Investments
166.5M 304.9M 180.45M 34.99M
Other Investing Acitivies
42.43M -430K 34.54M -33M
Investing Cash Flow
80.76M 43.86M 11.7M 15.41M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
417K 527K 696K 354.89M
Financial Cash Flow
417K 127.39M 166.23M 354.89M
Net Cash Flow
-3.82M 4.39M -59.21M 163.27M
Free Cash Flow
-85.7M -180.72M -259.98M -226.61M